Dr. Marcela Ioana Dobren, MD

Dr. Dobren practices at Baptist Primary Care Inc in Jacksonville, Florida.

Dr. Dobren's NPI, 1104197979, was assigned on January 25, 2012. Dr. Dobren graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 2003. Dr. Dobren holds Florida license ME113433.

Dr. Dobren's primary practice is Baptist Primary Care Inc, at 3563 Philips Hwy, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 260-1818.

Dr. Dobren's primary practice is Baptist Primary Care Inc in Jacksonville, Florida. Dr. Dobren is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist Primary Care. Dmand AI also links Dr. Dobren to 2 more hospitals, 5 skilled nursing facilities, 3 group practices and clinics, 2 hospices and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dobren practices, 13 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dobren's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dobren is board certified in internal medicine by the American Board of Internal Medicine. Dr. Dobren is licensed in Florida.

CMS data shows 769 Medicare services from Dr. Dobren across 6 procedure codes in 2024, for 374 Medicare patients. Medicare paid $64,915 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 374 Medicare patients who saw Dr. Dobren in 2024. The largest group is 85 and over, with 180 patients. 75% of them have arthritis, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dobren's median patient age at 81, with 65% women.

In 2024, Dr. Dobren wrote 13,844 Medicare Part D claims for 378 patients. 89% of them were for generic drugs. CMS names the drug for 13,266 of them, across 172 drugs with 11 or more claims each, at $547,174 in total drug cost. In 2023, CMS named 11,254 claims across 179 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Dobren for performance year 2024, reported through an alternative payment model (APM). Dr. Dobren accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Dobren from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $117.

Dr. Dobren graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 2003. Dr. Dobren is a member of SHM.

Dr. Dobren is in network with 2 carriers, including Elevance and Pacific Source Health Plans. PPO plans come from the most carriers, 2. Check the plan with the practice before a visit.